Barriers to this include adult cutoffs or a single set of cutoff points across all age groups, lack of normative data for plasma insulin level, pubertal insulin resistance, and lack of central obesity (waist) cutoff points in majority of the study settings. The gene discussed is INS; the disease is Insulin resistance.